Application of an agr-Specific Antivirulence Compound as Therapy for Staphylococcus aureus-Induced Inflammatory Skin Disease
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Application of an agr-Specific Antivirulence Compound as Therapy for Staphylococcus aureus-Induced Inflammatory Skin Disease
Final published version, 2.82 MB, PDF document
Atopic dermatitis (AD) is a chronic inflammatory skin disease where more than 90% of patients affected are colonized with Staphylococcus aureus. In AD, S. aureus δ-toxin is a major virulence factor causing cutaneous inflammation via mast cell degranulation. δ-toxin is controlled by the S. aureus agr quorum sensing system, and thus we addressed whether interference with agr signaling would limit skin inflammation. Indeed, treatment of S. aureus with the agr-inhibitor solonamide B (SolB) abolished δ-toxin production and reduced skin inflammation in a mouse model of inflammatory skin disease, demonstrating the potential of antivirulence therapy in treating S. aureus-induced skin disorders.
Original language | English |
---|---|
Journal | Journal of Infectious Diseases |
Volume | 218 |
Issue number | 6 |
Pages (from-to) | 1009-1013 |
ISSN | 0022-1899 |
DOIs | |
Publication status | Published - 2018 |
- Staphylococcus aureus, agr quorum sensing inhibition, atopic dermatitis, delta-toxin, antivirulence therapy
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 202979987